Company Announcements

Board Committees Appointments

Source: RNS
RNS Number : 0372A
Avast PLC
23 May 2019
 

 

Avast Plc

(the "Company")

Avast plc announces Board Committees Appointments

23 April 2019

Avast plc announces that it has appointed Belinda Richards, Independent Non-Executive Director of the Company, as the chair of the Audit and Risk Committee, with effect from 22 May 2019. Belinda will no longer serve as a member of Company´s Nomination Committee. Erwin Gunst, previous chair of the Audit and Risk Committee, will remain a committee member.

In addition:

 

-     Maggie Chan Jones, Independent Non-Executive Director of the Company, has been appointed as a member of the Remuneration and Nomination Committees of the Company; and

 

-     Tamara Minick-Scokalo, Independent Non-Executive Director of the Company, has been appointed as a member of the Audit and Risk Committee of Avast plc,

 

in each case with effect from 22 May 2019.

About Avast

Avast (LSE:AVST) is the global leader in digital security products. With over 400 million users online, Avast offers products under the Avast and AVG brands that protect people from threats on the internet and the evolving IoT threat landscape. The company's threat detection network is among the most advanced in the world, using machine learning and artificial intelligence technologies to detect and stop threats in real time. Avast digital security products for Mobile, PC or Mac are top-ranked and certified by VB100, AV-Comparatives, AV-Test, OPSWAT, West Coast Labs and others. Visit: www.avast.com.

Enquiries:

Peter Russell, Director of Investor Relations, ir@avast.com

Stephanie Kane, VP PR and Corporate Communications, mediarelations@avast.com

Jos Simson, Lulu Bridges, Tavistock, +44 20 7920 3150

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAAJMITMBMTBLL